Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -4.177% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: Cc1ccc2sc(NC(=O)CN3C(=O)c4ccccc4C3=O)nc2c1C
b: C[C@H]1C=C(C(=O)NCc2ccccc2)O[C@@H](OCc2ccc(CO)cc2)C1
c: COc1ccc(N2CCN(/C(=N\S(=O)(=O)c3ccccc3)Nc3nc(C)cc(C)n3)CC2)cc1
d: COC(=O)C(Cc1ccc(O)cc1)NC(=O)C12CC3CC(CC(C3)C1)C2
e: O=C(CCNS(=O)(=O)c1cccc2nsnc12)NCCc1ccccc1
Answer: e. O=C(CCNS(=O)(=O)c1cccc2nsnc12)NCCc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCNS(=O)(=O)c1cccc2nsnc12)NCCc1ccccc1
O=C(CCNS(=O)(=O)c1cccc2nsnc12)NCCc1ccccc1
3-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-(2-phenylethyl)propanamide